Tennessee Subject | Drugs, Prescription

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
TNHB0656EngrossAs introduced, specifies that within 10 days of receiving the nonresidential buprenorphine guidelines and standards a health-related board that licenses any practitioner authorized to prescribe buprenorphine must post such guidelines and standards on...
[Detail][Text][Discuss]
2019-04-18
Received from House, Passed on First Consideration
TNSB1215IntroAs introduced, removes restrictions on coverage of off-label drugs by insurers; removes definitions of medical literature and standard reference compendia. - Amends TCA Title 56; Title 63 and Title 71.
[Detail][Text][Discuss]
2019-04-16
To Senate Commerce and Labor Committee
TNHB0843PassAs enacted, makes various changes concerning the prescription of certain Scheduled controlled substances. - Amends TCA Title 53, Chapter 10, Part 3; Title 63, Chapter 1, Part 1 and Title 63, Chapter 1, Part 4.
[Detail][Text][Discuss]
2019-04-15
Comp. became Pub. Ch. 124
TNSB0810PassAs enacted, makes various changes concerning the prescription of certain Scheduled controlled substances. - Amends TCA Title 53, Chapter 10, Part 3; Title 63, Chapter 1, Part 1 and Title 63, Chapter 1, Part 4.
[Detail][Text][Discuss]
2019-04-15
Pub. Ch. 124
TNHB1010IntroAs introduced, removes restrictions on coverage of off-label drugs by insurers; removes definitions of medical literature and standard reference compendia. - Amends TCA Title 56; Title 63 and Title 71.
[Detail][Text][Discuss]
2019-04-15
Returned to the Clerk's Desk.
TNSB0475IntroAs introduced, requires that Schedule II opioids, Schedule II stimulants, and Schedule IV benzodiazepines be dispensed in a lockable vial; provides exceptions where it is not practicable to dispense the controlled substance in a lockable vial or ther...
[Detail][Text][Discuss]
2019-04-10
Deferred to Summer Study
TNSB1060IntroAs introduced, specifies that within 10 days of receiving the nonresidential buprenorphine guidelines and standards a health-related board that licenses any practitioner authorized to prescribe buprenorphine must post such guidelines and standards on...
[Detail][Text][Discuss]
2019-04-10
To Senate Health and Welfare Committee
TNSB0963IntroAs introduced, enacts the "Prescription Drug Fair Pricing Act." - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
[Detail][Text][Discuss]
2019-04-09
To Senate Commerce and Labor Committee
TNHB0364IntroAs introduced, requires that Schedule II opioids, Schedule II stimulants, and Schedule IV benzodiazepines be dispensed in a lockable vial; provides exceptions where it is not practicable to dispense the controlled substance in a lockable vial or ther...
[Detail][Text][Discuss]
2019-04-02
Def. to Summer Study in Health Committee
TNHB0887IntroAs introduced, enacts the "Prescription Drug Fair Pricing Act." - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
[Detail][Text][Discuss]
2019-02-11
Assigned to s/c Mental Health & Substance Abuse Subcommittee
TNSB0202IntroAs introduced, requires that Schedule II opioids, Schedule II stimulants, and Schedule IV benzodiazepines be dispensed in a lockable vial; provides exceptions where it is not practicable to dispense the controlled substance in a lockable vial or ther...
[Detail][Text][Discuss]
2019-01-29
Withdrawn.
Syndicate content
feedback